Schivo has acquired Mecaplast SA, a Swiss manufacturer of injection-molded plastics, metals and ceramics for the medical device and life sciences sectors.
Mecaplast's ISO 13485-certified facility spanning more than 64,000 square feet is used for micro-molding, over-molding, injection molding, mold manufacturing, cleanroom assembly, and automation.
"Mecaplast brings decades of deep expertise in complex plastics, metals and ceramics, perfectly aligning with our vision of creating a global, multi-capability platform for advanced medical and Life Sciences devices serving the robotic surgical, minimally invasive surgical and analytical instrumentation segments," said Graham Reeves, CEO of Schivo. "Their dedication to innovation further enhances our ability to deliver fully integrated solutions across materials, technologies, and international markets."
The Mecaplast SA facility will serve as Schivo's Global Center of Excellence for molding and precision plastics, metal and ceramics. Jean-Marc Jaccottet will join Schivo's leadership team as President of Molding Technologies, leading R&D and innovation while driving the group's capacity growth, positioning it as a key driver in advanced molding solutions.
